logo dark logo light logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS
    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
logo dark logo light logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS
    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
mobile-logo
  • COMPANY
    • TIMELINE
    • TEAM
  • THE CAPSULE
  • RESEARCH
    • CLINICAL RESEARCH
    • TRIALS
    • PUBLICATIONS
  • NEWS
    • MEDIA RELEASES
    • MEDIA COVERAGE
  • CONTACT
  • LOGINS

    • CLINICIAN PORTAL
    • RESOURCE LIBRARY
14 Oct

Atmo CEO Mal Hebblewhite interviewed on ausbiz

by Danni Sweeting
in 2020 News, News
Comments

Atmo CEO Malcolm Hebblewhite was interviewed live in the ausbiz studio about how Atmo Biosciences can improve diagnosis and management of gastrointestinal disorders....

Read More

Contact

info@atmobiosciences.com

Australia

436 Elgar Rd
Box Hill VIC 3128

United States

Atmo Biosciences Inc.
7625 Golden Triangle Dr., Ste G
Eden Prairie, MN 55344
  • Clinician Portal Login
  • Support and Resources
  • Privacy Policy
  • USA
  • Terms and Conditions of Sale
  • Business Associate Agreement
Honoree – World Changing Ideas for 2026

© Atmo Biosciences 2026

loading

Please wait while you are redirected to the right region...